| | | |   | | | | By Ed Silverman Kris Connor/Getty Images for A+E Networks The goal is to offer employers a new option for prescription drugs while also capturing much of the same data that may be lost to GoodRx. Read More | | By Bob Herman Chip Somodevilla/Getty Images Medicare is willing to reevaluate its coverage of Alzheimer’s drugs in light of a new therapy, called lecanemab, the CMS director said. Read More | | By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT's Elaine Chen joins us to explain how the escalating demand for a diabetes drug is putting people with obesity in a difficult situation. Read More | | By Helen Branswell JOSEPH PREZIOSO/AFP via Getty Images Previously, the bivalent boosters, which protect against two different strains of the SARS-CoV-2 virus, were available to kids 5 and older. Read More | | Sponsored Insight by Brunswick Healthcare communications: The bar is higher than ever The pandemic has made everyone on the planet a health information consumer, heightening the demands on healthcare companies to develop and deliver timely, practical information. These companies also need to communicate with a much larger set of audiences, not just industry insiders and experts. Brunswick helps healthcare companies navigate this new, more demanding landscape, by combining our deep sector knowledge with our understanding of the issues and messages that matter to innovators, investors, patients, providers, and the public. Learn about the company’s healthcare practice and how they can help you tell your best story. | | By Ambar Castillo Milken Institute Language barriers, geography, and low income levels are common obstacles for patients hoping to enroll in rare disease clinical trials. Read More | |
No comments